Association of body mass index and prostate cancer mortality

Obesity Research and Clinical Practice

Volumn 8, Issue 4, 2014, Pages

  Haque, Reina ^a   Van Den Eeden, Stephen K ^b   Wallner, Lauren P ^a   Richert Boe, Kathryn ^d   Kallakury, Bhaskar ^c   Wang, Renyi ^a   Weinmann, Sheila ^d  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

BMI; Case control; Population sciences; Prostate cancer; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER THERAPY; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; VERY ELDERLY; CANCER GRADING; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; OBESITY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84905594127     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2013.06.002     Document Type: Article

References (31)

1. American Cancer Society Cancer Facts & Figures 2010 2010 American Cancer Society Atlanta
2. K.M. Flegal, M.D. Carroll, C.L. Ogden, and L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
3. C.L. Amling, R.H. Riffenburgh, L. Sun, J.W. Moul, R.S. Lance, and L. Kusuda et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
4. W.W. Bassett, M.R. Cooperberg, N. Sadetsky, S. Silva, J. DuChane, and D.J. Pasta et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE Urology 66 2005 1060 1065
5. S.J. Freedland, W.J. Aronson, C.J. Kane, J.C. Presti Jr., C.L. Amling, and D. Elashoff et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446 453
6. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
7. R.J. MacInnis, and D.R. English Body size and composition and prostate cancer risk: systematic review and meta-regression analysis Cancer Causes Control 17 2006 989 1003
8. R.J. MacInnis, D.R. English, D.M. Gertig, J.L. Hopper, and G.G. Giles Body size and composition and prostate cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 1417 1421
9. C.L. Parr, G.D. Batty, T.H. Lam, F. Barzi, X. Fang, and S.C. Ho et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants Lancet Oncol 11 2010 741 752
10. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
11. C. Rodriguez, A.V. Patel, E.E. Calle, E.J. Jacobs, A. Chao, and M.J. Thun Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
12. F.M. Jhaveri, C.D. Zippe, E.A. Klein, and P.A. Kupelian Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10 year results Urology 54 1999 884 890
13. S.J. Freedland, E.B. Humphreys, L.A. Mangold, M. Eisenberger, F.J. Dorey, and P.C. Walsh et al. Risk of prostate-cancer specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
14. Z. Gong, I. Agalliu, D.W. Lin, J.L. Stanford, and A.R. Kristal Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men Cancer 109 2007 1192 1202
15. National Heart Lung Blood Institute. http://nhlbisupport.com/bmi/ [accessed 1.10.12].
16. World Health Organization. http://apps.who.int/bmi/index.jsp?introPage= intro-3.html [accessed 20.05.13].
17. R. Prentice Use of the logistic model in retrospective studies Biometrics 32 1976 599 606
18. H.S. Lynn, and C.E. McCulloch When does it pay to break the matches for analysis of a matched-pairs design? Biometrics 48 1992 397 409
19. N.E. Breslow, and N.E. Day Statistical methods in cancer research: the analysis of case-control studies IARC Sci Publ 1980 5 338
20. S.J. Freedland, L.L. Bañez, L.L. Sun, N.J. Fitzsimons, and J.W. Moul Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database Prostate Cancer Prostatic Dis 12 2009 259 263
21. Y. Cao, and J. Ma Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis Cancer Prev Res (Phila) 4 2011 486 501
22. C. Rodriguez, S.J. Freedland, A. Deka, E.J. Jacobs, M.L. McCullough, and A.V. Patel et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol Biomarkers Prev 16 2007 63 69
23. Z. Gong, M.L. Neuhouser, P.J. Goodman, D. Albanes, C. Chi, and A.W. Hsing et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial Cancer Epidemiol Biomarkers Prev 15 2006 1977 1983
24. A. Bill-Axelson, L. Holmberg, F. Filén, M. Ruutu, H. Garmo, and C. Busch et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 2008 1144 1154
25. M.J. Khandekar, P. Cohen, and B.M. Spiegelman Molecular mechanisms of cancer development in obesity Nat Rev Cancer 11 2011 886 895
26. S.J. Freedland, E.B. Humphreys, L.A. Mangold, M. Eisenberger, and A.W. Partin Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality J Urol 176 4 Pt 1 2006 1404 1408
27. L.P. Wallner, H. Morgenstern, M.E. McGree, D.J. Jacobson, J.L. St Sauver, and S.J. Jacobsen et al. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection Cancer Epidemiol Biomarkers Prev 20 2011 501 508
28. J.C. Massengill, L. Sun, J.W. Moul, H. Wu, D.G. McLeod, and C. Amling et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy J Urol 169 2003 1670 1675
29. G. Schatzl, S. Madersbacher, T. Thurridl, J. Waldmüller, G. Kramer, and A. Haitel et al. High-grade prostate cancer is associated with low serum testosteronelevels Prostate 47 2001 52 58
30. M.A. Rowlands, D. Gunnell, R. Harris, L.J. Vatten, J.M. Holly, and R.M. Martin Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic reviewand meta-analysis Int J Cancer 124 2009 2416 2429
31. M.A. Rowlands, J.M. Holly, D. Gunnell, J. Donovan, J.A. Lane, and F. Hamdy et al. Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT Cancer Res 72 2012 503 515